Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.

Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P.

Eur J Gastroenterol Hepatol. 2019 May;31(5):626-632. doi: 10.1097/MEG.0000000000001342.

PMID:
30550458
2.

Reply to the letter to the Editor.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Nov-Dec;15(6):947-948. No abstract available.

3.

 Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Mar-Apr;15(2):200-6. doi: 10.5604/16652681.1193710.

4.

Reply to the letter to the Editor.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Nov - Dec;15(6):947-948. doi: 10.5604/16652681.1222120. No abstract available.

5.

Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Mar - Apr;15(2):200-206. doi: 10.5604/16652681.1193710.

6.

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.

Falleti E, Cussigh A, Cmet S, Fabris C, Toniutto P.

Dig Liver Dis. 2016 Jan;48(1):69-75. doi: 10.1016/j.dld.2015.09.009. Epub 2015 Sep 28.

PMID:
26493626
7.

Corrigendum: PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.

Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Ulrich S, Daly A, Day CP, Kuo YF, Singal AK.

Am J Gastroenterol. 2015 Jul;110(7):1121. doi: 10.1038/ajg.2015.181. No abstract available.

PMID:
26148270
8.

PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.

Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Spengler U, Daly A, Day CP, Kuo YF, Singal AK.

Am J Gastroenterol. 2015 Jun;110(6):846-56. doi: 10.1038/ajg.2015.137. Epub 2015 May 12. Review. Erratum in: Am J Gastroenterol. 2015 Jul;110(7):1121. Ulrich, Spengler [corrected to Spengler, Ulrich].

PMID:
25964223
9.

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.

Toniutto P, Bitetto D, Falleti E, Vadalà S, Cmet S, Cussigh A, Bulajic M, Zilli M, Fabris C.

Int J Surg. 2014 Oct;12(10):1082-7. doi: 10.1016/j.ijsu.2014.09.004. Epub 2014 Sep 16.

10.

Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome.

Ginanni Corradini S, Siciliano M, Parlati L, Molinaro A, Cantafora A, Poli E, Mennini G, Melandro F, Vestri AR, Merli M, Bianco P, Corsi A, Toniutto P, Bitetto D, Falleti E, Attili AF, Berloco P, Rossi M.

Liver Int. 2014 Aug;34(7):e290-301. doi: 10.1111/liv.12351. Epub 2013 Nov 20.

PMID:
24256518
11.

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Fattovich G, Cussigh A, Bitetto D, Ceriani E, Lenisa I, Dissegna D, Ieluzzi D, Rostello A, Pirisi M, Toniutto P.

PLoS One. 2013 Nov 14;8(11):e80764. doi: 10.1371/journal.pone.0080764. eCollection 2013.

12.

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.

Trépo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, Hamza S, Corradini SG, Burza MA, Guyot E, Donati B, Spengler U, Hillon P, Toniutto P, Henrion J, Franchimont D, Devière J, Mathurin P, Moreno C, Romeo S, Deltenre P.

Hepatology. 2014 Jun;59(6):2170-7. doi: 10.1002/hep.26767. Epub 2014 Apr 25.

PMID:
24114809
13.

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Bitetto D, De Feo T, Mantovani M, Falleti E, Fabris C, Belli LS, Fagiuoli S, Burra P, Piccolo G, Donato MF, Toniutto P; AISF RECOLT Study Group, Cmet S, Cussigh A, Viganò R, Airoldi A, Pasulo L, Colpanij M, De Martin E, Gambato M, Rigamonti C.

Dig Liver Dis. 2013 Nov;45(11):927-32. doi: 10.1016/j.dld.2013.04.006. Epub 2013 May 27.

PMID:
23722013
14.

Reply: To PMID 22610885.

Falleti E, Fabris C, Toniutto P.

Hepatology. 2013 Nov;58(5):1864-5. doi: 10.1002/hep.26435. Epub 2013 Sep 13. No abstract available.

PMID:
23553733
15.

Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy.

Bitetto D, Bortolotti N, Falleti E, Vescovo S, Fabris C, Fattovich G, Cussigh A, Cmet S, Fornasiere E, Ceriani E, Pirisi M, Toniutto P.

Hepatology. 2013 Mar;57(3):925-33. doi: 10.1002/hep.26186. Epub 2013 Feb 7.

PMID:
23213086
16.

Toll like receptor 4 D299G associates with disease progression in Caucasian patients with chronic HBV infection: relationship with gender.

Cussigh A, Fabris C, Fattovich G, Falleti E, Cmet S, Bitetto D, Bignulin E, Toniutto P.

J Clin Immunol. 2013 Feb;33(2):313-6. doi: 10.1007/s10875-012-9822-9. Epub 2012 Oct 24.

PMID:
23093310
17.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, Ceriani E, Fornasiere E, Pasino M, Ieluzzi D, Pirisi M, Toniutto P.

Hepatology. 2012 Nov;56(5):1641-50. doi: 10.1002/hep.25848. Epub 2012 Oct 14.

PMID:
22610885
18.

Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.

Bitetto D, Fabris C, Falleti E, Fornasiere E, Avellini C, Cmet S, Cussigh A, Fontanini E, Pirisi M, Corradini SG, Merli M, Molinaro A, Toniutto P.

Transplantation. 2012 May 27;93(10):1038-44. doi: 10.1097/TP.0b013e31824df7f3.

PMID:
22495472
19.

The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Colletta C, Vandelli C, Cmet S, Ceriani E, Smirne C, Toniutto P, Pirisi M.

J Med Virol. 2012 May;84(5):747-55. doi: 10.1002/jmv.23259.

PMID:
22431022
20.

Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.

Cmet S, Fabris C, Fattovich G, Falleti E, Bitetto D, Cussigh A, Fontanini E, Fornasiere E, Pirisi M, Toniutto P.

Clin Exp Immunol. 2012 Feb;167(2):296-302. doi: 10.1111/j.1365-2249.2011.04497.x.

21.

Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients.

Falleti E, Bitetto D, Fabris C, Cmet S, Fornasiere E, Cussigh A, Fontanini E, Avellini C, Barbina G, Ceriani E, Pirisi M, Toniutto P.

Transpl Int. 2012 Mar;25(3):314-22. doi: 10.1111/j.1432-2277.2011.01419.x. Epub 2012 Jan 3.

22.

Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Bitetto D, Cussigh A, Fornasiere E, Bignulin E, Feruglio C, Mosanghini E, Fontanini E, Pirisi M, Toniutto P.

Cytokine. 2012 Jan;57(1):68-73. doi: 10.1016/j.cyto.2011.10.018. Epub 2011 Nov 27.

PMID:
22122913
23.

Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.

Minisini R, Giarda P, Grossi G, Bitetto D, Toniutto P, Falleti E, Avellini C, Occhino G, Fabris C, Pirisi M.

J Gastroenterol. 2011 Nov;46(11):1307-15. doi: 10.1007/s00535-011-0440-8. Epub 2011 Jul 23.

PMID:
21789480
24.

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.

Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P.

Liver Int. 2011 Sep;31(8):1137-43. doi: 10.1111/j.1478-3231.2011.02534.x. Epub 2011 Apr 19.

PMID:
21745286
25.

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, Fumolo E, Bignulin S, Fontanini E, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Clin Immunol. 2011 Oct;31(5):891-9. doi: 10.1007/s10875-011-9547-1. Epub 2011 Jun 7.

PMID:
21647799
26.

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, Pasino M, Ieluzzi D, Cussigh A, Cmet S, Pirisi M, Toniutto P.

Hepatology. 2011 Apr;53(4):1118-26. doi: 10.1002/hep.24201.

PMID:
21480318
27.

Vitamin D deficiency and HCV chronic infection: what comes first?

Bitetto D, Fabris C, Falleti E, Toniutto P.

J Hepatol. 2011 Oct;55(4):944-5; author reply 945. doi: 10.1016/j.jhep.2011.01.044. Epub 2011 Feb 22. No abstract available.

28.

Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.

Fabris C, Vandelli C, Toniutto P, Minisini R, Colletta C, Falleti E, Smirne C, Pirisi M.

J Gastroenterol Hepatol. 2011 Feb;26(2):328-33. doi: 10.1111/j.1440-1746.2010.06403.x.

PMID:
21261723
29.

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Hepatol. 2011 Apr;54(4):716-22. doi: 10.1016/j.jhep.2010.07.019. Epub 2010 Sep 19.

PMID:
21146242
30.

Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C.

Cussigh A, Falleti E, Fabris C, Bitetto D, Cmet S, Fontanini E, Bignulin S, Fornasiere E, Fumolo E, Minisini R, Pirisi M, Toniutto P.

Immunogenetics. 2011 Jan;63(1):33-41. doi: 10.1007/s00251-010-0491-7. Epub 2010 Nov 12.

PMID:
21072509
31.

Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C.

Falleti E, Fabris C, Vandelli C, Colletta C, Cussigh A, Smirne C, Fontanini E, Cmet S, Minisini R, Bitetto D, Toniutto P, Pirisi M.

Hum Immunol. 2010 Oct;71(10):999-1004. doi: 10.1016/j.humimm.2010.06.006. Epub 2010 Jul 22.

PMID:
20655350
32.

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, Cmet S, Fontanini E, Falleti E, Martinella R, Pirisi M, Toniutto P.

Transpl Int. 2011 Jan;24(1):43-50. doi: 10.1111/j.1432-2277.2010.01141.x.

33.

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis.

Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, Fornasiere E, Fumolo E, Bignulin S, Cmet S, Minisini R, Pirisi M, Toniutto P.

World J Gastroenterol. 2010 Jun 28;16(24):3016-24.

34.

Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease.

Fontanini E, Cussigh A, Fabris C, Falleti E, Toniutto P, Bitetto D, Cmet S, Fumolo E, Fornasiere E, Bignulin S, Pinato DJ, Minisini R, Pirisi M.

Inflammation. 2010 Aug;33(4):251-8. doi: 10.1007/s10753-009-9179-2.

PMID:
20087638
35.

Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B.

Toniutto P, Fattovich G, Fabris C, Minisini R, Burlone M, Pravadelli C, Peraro L, Falleti E, Caldera F, Bitetto D, Pirisi M.

J Med Virol. 2010 Feb;82(2):224-331. doi: 10.1002/jmv.21642.

PMID:
20029801
36.

Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.

Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fumolo E, Fornasiere E, Bragagnini W, Pinato DJ, Minisini R, Pirisi M.

Oncology. 2009;77(5):304-13. doi: 10.1159/000260057. Epub 2009 Nov 20.

PMID:
19940521
37.

Vitamin D and the risk of acute allograft rejection following human liver transplantation.

Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E, Cussigh A, Occhino G, Baccarani U, Pirisi M, Toniutto P.

Liver Int. 2010 Mar;30(3):417-44. doi: 10.1111/j.1478-3231.2009.02154.x. Epub 2009 Oct 22.

PMID:
19849776
38.

Physical training effects in renal transplant recipients.

Romano G, Simonella R, Falleti E, Bortolotti N, Deiuri E, Antonutto G, De Vita S, Ferraccioli GF, Montanaro D.

Clin Transplant. 2010 Jul-Aug;24(4):510-4. doi: 10.1111/j.1399-0012.2009.01098.x.

PMID:
19788449
39.

Gene polymorphism at the interleukin 6 -174 G > C locus affects the outcome of chronic hepatitis B.

Fabris C, Toniutto P, Bitetto D, Fattovich G, Falleti E, Fontanini E, Cussigh A, Minisini R, Occhino G, Pirisi M.

J Infect. 2009 Aug;59(2):144-5. doi: 10.1016/j.jinf.2009.06.005. Epub 2009 Jun 18. No abstract available.

PMID:
19595462
40.

Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C.

Fabris C, Smirne C, Fangazio S, Toniutto P, Burlone M, Minisini R, Bitetto D, Falleti E, Cerutti A, Pirisi M.

Hepatol Res. 2009 Aug;39(8):795-804. doi: 10.1111/j.1872-034X.2009.00518.x. Epub 2009 Apr 23.

PMID:
19456900
41.

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia.

Rossi D, Sala L, Minisini R, Fabris C, Falleti E, Cerri M, Burlone ME, Toniutto P, Gaidano G, Pirisi M.

Leuk Lymphoma. 2009 Apr;50(4):604-11. doi: 10.1080/10428190902777673.

PMID:
19373659
42.

MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.

Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Fumolo E, Avellini C, Minisini R, Pirisi M.

Alcohol Clin Exp Res. 2009 Jan;33(1):102-7. doi: 10.1111/j.1530-0277.2008.00816.x. Epub 2008 Oct 18.

PMID:
18945219
43.

TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.

Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R, Pirisi M.

Cytokine. 2008 Nov;44(2):256-61. doi: 10.1016/j.cyto.2008.08.008. Epub 2008 Sep 21.

PMID:
18809335
44.

Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation.

Toniutto P, Fabris C, Fumolo E, Bitetto D, Fornasiere E, Falleti E, Rapetti R, Minisini R, Pirisi M.

Liver Transpl. 2008 Jul;14(7):1014-9. doi: 10.1002/lt.21465.

45.

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C.

Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Leutner M, Pirisi M.

Clin Chem Lab Med. 2008;46(2):253-9. doi: 10.1515/CCLM.2008.051.

PMID:
18324909
46.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1904-8.

PMID:
17914968
47.

Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.

Toniutto P, Fabris C, Falleti E, Cussigh A, Fontanini E, Bitetto D, Fornasiere E, Minisini R, De Feo T, Marangoni F, Pirisi M.

Liver Int. 2008 Feb;28(2):257-63. Epub 2007 Sep 26.

PMID:
17900242
48.

Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis.

Quartuccio L, Fabris M, Salvin S, Isola M, Soldano F, Falleti E, Beltrami CA, De Re V, De Vita S.

Rheumatology (Oxford). 2007 Nov;46(11):1657-61. Epub 2007 Sep 24.

PMID:
17893101
49.

Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood.

Don M, Valent F, Korppi M, Falleti E, De Candia A, Fasoli L, Tenore A, Canciani M.

Scand J Infect Dis. 2007;39(2):129-37.

PMID:
17366029
50.

Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C.

Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Caldato M, Rossi E, Bitetto D, Minisini R, Smirne C, Pirisi M.

J Interferon Cytokine Res. 2007 Mar;27(3):239-46.

PMID:
17348823

Supplemental Content

Loading ...
Support Center